Related Experiment Video
Updated: Apr 5, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Do "Developing" Countries Become "Developed"? Lessons from Helicobacter pylori Infection Recurrence Rate after
1Adelson Faculty of Medicine, Ariel University, Ariel, Israel, nivy@ariel.ac.il.
Background:
The World Bank classified "developing countries" as all 135 countries with low- or middle-income economies, whose 6.7 billion people represent 84% of the world's population. Other parameters, such as household crowding, poor sanitation, reduced income, limited education, and unsafe drinking water, are often used to refine this definition. A wide range of prevalence, from 18.9% in Switzerland to 87.7% in Nigeria, is reported, and the association between Helicobacter pylori infection and socioeconomic status is well established. After successful eradication, infection can recur due to recrudescence or reinfection.
Summary:
We compared the results of our two meta-analyses from 2008 to 2024, demonstrating the recurrence rates in developing versus developed countries. We also looked at the continuous change over time in the recurrence rate of H. pylori after a successful eradication in developing countries. We found that the disparity between "developed" and "developing" countries in the recurrence of H. pylori infection has disappeared, following a continuous decrease in recurrence rates of H. pylori in developing countries.
Key Messages:
We assume that H. pylori recurrence may be a marker for the socioeconomic state, and our results point toward a process in which "developing" countries advance toward becoming "developed."
More Related Videos
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...